Sanger Institute Purchases PacBio RS Single-Molecule Sequencer
August 03, 2010
Sanger Institute Purchases PacBio RS Single-Molecule Sequencer
The company has expanded its early-access program to a “limited number” of sites outside North America. It previously said it is interested in having testing sites in Europe and Asia.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Sanger Institute's Performance Comparison of PGM, MiSeq, PacBio RS Highlights Key Differences
July 31, 2012 / In Sequence - Eurofins MWG Operon Launches Sequencing Services on PacBio RS
May 31, 2011 / In Sequence - Early Users Weigh in on PacBio RS; Report on Strobe Sequencing, Hybrid Assembly with Illumina
May 17, 2011 / In Sequence - PacBio Raises IPO Target to $230M, Enacts 1-for-2 Reverse Stock Split, Prices Shares
October 5, 2010 / In Sequence - PacBio Sequencing to Support 100K Genome Project
January 8, 2013 / GenomeWeb Daily News